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A surge in the level and scale of antibiotic resistance has prompted renewed interest in
the application of bacteriophages to treat bacterial infections. However, concerns still
exist over their efficacy and safety. Acinetobacter baumannii phage BS46, a member
of the family Myoviridae, has previously been shown to be effective in murine models.
The cytotoxic effect of this phage was evaluated in mouse fibroblast 3T3 cells using
four different assays: trypan blue; staining with Hoechst and propidium iodide; lactate
dehydrogenase release; and the MTS assay. The addition of phage concentrations up
to 2 × 109 pfu/mL showed little to no impact on the viability of 3T3 cells after 24 h
exposure using the different assays. This study demonstrates that phage BS46 is non-
cytotoxic to 3T3 cells using four different assays and that appropriate quality assurance
protocols for phage therapeutics are required.
Keywords: bacteriophage, cytotoxicity, Acinetobacter baumannii, lactate dehydrogenase, MTS assay, trypan
blue, hoechst stain, propidium iodide
INTRODUCTION
There is a resurgence of interest in phage to treat multidrug resistant infections in humans, with
some bacteriophage (phage) products entering clinical trials (Rhoads et al., 2009; Wright et al.,
2009) or in animal testing (Biswas et al., 2002; Morello et al., 2011). Although the use of phages
within a clinical setting dates back to the early part of the 20th Century (Kutter et al., 2010), their
use has been primarily confined to the former Soviet Union and Eastern Europe, in part due to
concerns about safety and efficacy (Hanlon, 2007). Small numbers of phage preparations have
been approved by the U.S. Food & Drug Administration for use as food additives within the food
industry for the control of Listeria monocytogenes (Bren, 2007) and within the European Union
(Anonymous, 2012). The small amount of human clinical trial data that exists in currently available
literature has not demonstrated toxicity issues (Merabishvili et al., 2009). However, the potential to
induce an immune response regardless of the level of preparation purity is of major concern to
those seeking to utilize phage therapy clinically. There are a number of assays available to measure
cell cytotoxicity. These often differ in the parameters they measure and have been shown to exhibit
different levels of sensitivity (Fotakis and Timbrell, 2006). No standard assay for determining the
cytotoxic effect of phage has been reported.
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Acinetobacter baumannii is an opportunistic human pathogen
causing a wide range of infections including wound, urinary
tract infections (Antunes et al., 2014) and ventilator-acquired
pneumonia (Qureshi et al., 2015). A. baumannii is an important
multidrug resistant microorganism (Cai et al., 2012; Zarrilli
et al., 2013; Antunes et al., 2014), with resistance to colistin
being recently reported (Qureshi et al., 2015). The use of phages
against this important pathogen is an exciting prospect, but
for application in humans, particularly for wound infections,
their cytotoxicity needs to be evaluated. Here the A. baumannii
phage BS46, a member of the Myoviridae family was used. It
has previously been shown to provide a protective effect in mice
when challenged with up to five times the LD50 (108 cfu) of
A. baumannii (Soothill, 1992).
The current investigation sought to determine the cytotoxic
effects of a single A. baumannii phage and to evaluate different
methods of determining cytotoxic effect following the addition of
bacteriophage.
MATERIALS AND METHODS
All chemicals and reagents were obtained from Fisher Scientific
(Loughborough, UK) or Sigma–Aldrich (Gillingham, UK) unless
otherwise stated in the text.
Sterile Lambda (λ) buffer was prepared by the addition of
2.5 mL 2% (w/v) gelatin to 6 mL 1 M Tris base at pH 7.2. To this
2.5 g MgSO4.7H20 was added and the resulting suspension made
up to 1 L with dH2O. The resulting solution was then autoclaved
at 121◦C for 15 min.
Routine Culture of Bacterial and
Bacteriophage Strains
Acinetobacter baumannii HER1401 and phage BS46 (Soothill,
1992; Ackermann et al., 1994) were obtained from The Felix
d’Hérelle Reference Center for Bacterial Viruses, GREB, Faculté
de Médecine Dentaire, Université Laval, Canada.
Acinetobacter baumannii HER1401 cultured in Tryptone Soy
Broth (TSB; Oxoid, Basingstoke, UK) for 18 h at 37◦C under
120 rpm agitation was used to inoculate 100 mL TSB. That was
then incubated for 3–5 h at 37◦C under 120 rpm agitation until an
OD600 of 0.5 (∼108 cfu/mL) was reached. Bacterial suspensions
were then infected with 1 mL phage suspension (∼106 pfu/mL),
statically incubated at 37◦C for 15 min and then incubated for a
further 18 h at 37◦C and 120 rpm.
Following incubation 10 mL chloroform was added and then
the suspensions were incubated at 37◦C, 120 rpm for 10 min
prior to centrifugation at 2500 × g for 10 min. The resulting
supernatant was then passed through a 0.45 µm syringe filter
(Millipore, UK) to produce a crude lysate.
Production of Concentrated Purified
Phage
Prior to use, crude lysates were enumerated and assessed for
viability using the agar overlay method (Adams, 1959). To
each crude lysate, sodium chloride was added to give a 1 M
final concentration, stored on ice for 1 h and centrifuged at
11000 × g for 10 min at 4◦C. Following centrifugation, 10%
(w/v) polyethylene glycol 8000 (PEG 8000) was added to the
supernatant and stored at 4◦C for 18 h.
Suspensions were centrifuged at 11000 × g for 10 min at 4◦C,
the supernatant discarded, the pellet re-suspended in 11 mL λ
buffer and 1 mL chloroform. The organic and aqueous phases
were separated by centrifugation at 3000 × g for 15 min at 4◦C.
The organic phase was discarded and the aqueous phase made up
to 50 mL with λ buffer and passed twice through 0.45 µm filters.
Purified phage preparations were diluted in λ buffer to provide
a working suspension of 8 × 109 pfu/mL and enumerated using
the agar overlay method as previously described (Adams, 1959)
and stored in sterile glass containers at 2–8◦C.
Prior to use in cytotoxicity experiments, phages were diluted
in λ buffer to yield 2 × 109, 2 × 108, and 2 × 107 pfu/mL and
suspensions equilibrated to room temperature.
Cell Culture
Acinetobacter baumannii is a known bacterial pathogen
associated with wounds. The embryonic Swiss albino mouse
fibroblast cell line ‘3T3(+3)’ ECACC No. 89022402 was used
here as a model since fibroblasts are associated with wound
healing. 3T3 cells were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 1 g/L glucose, L-glutamine
and sodium bicarbonate, 10% (v/v) fetal calf serum (FCS) and
1% (v/v) penicillin and streptomycin. All cells were incubated at
37◦C with 5% CO2 in a humidified atmosphere.
Analysis of Bacteriophage Cytotoxicity in
3T3 Cells
Preparation of Cells for Use in Cytotoxicity
Experiments
Working culture plates were produced by the addition of 5000,
10000, 15000, or 2 × 105 3T3 cells (depending on the assay
type) to wells of sterile Nunclon surface 24-well cell culture
plates (Nunc Denmark) into a total volume of 1 mL pre-warmed
supplemented DMEM and incubated for 24 h at 37◦C in 95% air:
5% CO2 in a humidified atmosphere.
In order to remove mouse fibroblast 3T3 cells from 24 well
plates, DMEM was removed, 200 µL of trypsin added to each
well and plates incubated for 3–5 min at 37◦C in a 95% air: 5%
CO2 atmosphere. Cell suspensions were centrifuged at 400 × g
for 5 min, the supernatant discarded and the pellet re-suspended
in 1 mL fresh DMEM.
Trypan Blue Exclusion Assay
3T3 cell suspensions and 50 µL purified phage in experimental
wells (n= 6) were prepared and incubated for 24, 48, and 72 h as
before. λ buffer was used as a negative control.
Following trypsinisation, cell viability was assessed using
a Trypan blue assay (Strober, 2001). In brief, 20 µL of cell
suspension was added to 4 µL 0.4% (w/v) trypan blue solution in
phosphate buffered saline (Sigma–Aldrich, Gillingham, UK) and
the total number of cells immediately quantified from five squares
of a haemocytometer at 100 × magnification using an inverted
light microscope (Wilovert standard; Hund Wetzlar, Germany).
Frontiers in Microbiology | www.frontiersin.org 2 August 2016 | Volume 7 | Article 1198
fmicb-07-01198 August 2, 2016 Time: 20:59 # 3
Henein et al. Non-cytotoxic Acinetobacter baumannii Phage Preparations
If the cell density was too high then cells were diluted 1:10 in
DMEM prior to imaging. Unstained cells were considered to be
alive while blue stained cells were considered to be dead. In all
cases, samples from each well were read in quintuplicate on two
different occasions.
Hoechst and Propidium Iodide Staining
for Cell Apoptosis
BS46 phages were inoculated to growing 3T3 cells as described
above. λ buffer was used as a negative control.
Viable and apoptotic cells were quantified at multiple time
points (t = 24, 48, 72 h) after phage addition using a modified
propidium iodide (PI) staining method (Belloc et al., 1994). In
brief, 900 µL of DMEM was mixed with 50 µL of a 1 mg/mL
(in 10 mL demineralized water) PI solution and 50 µL of
bisbenzimide. Wells were stained with PI and six random fields
of view counted using an Axiovert 25 inverted fluorescence
microscope (Karl Zeiss Ltd., Welwyn Garden City, UK) with
a 420 nm filter. Viable cells were identified by uniform blue
fluorescence and apoptotic cells by their fragmented nuclei with
either blue or pink fluorescence.
Lactate Dehydrogenase (LDH) Release
Lactate Dehydrogenase (LDH) values were determined using
the CytoTox 96 Non-Radioactive cytotoxicity assay (Promega,
Southampton, UK) according to the manufacturer’s instructions.
Absorbance at 492 nm was determined in an automatic Titertek
Multiskan Plus MKII plate reader (LabX, Midland, ON, Canada),
at 492 nm. Absorbance values were adjusted to compensate
for the contribution of DMEM and the percentage cytotoxicity
calculated as below;
% Cytotoxicity= [Experimental LDH release/Maximum LDH
release]× 100.
Cell Viability Using an MTS Assay
Fifty micro liter of purified phage suspension were added to
the experimental wells and incubated for 24, 48, and 72 h as
described above. Negative controls containing 50 µL λ buffer
and untreated cells were also performed. The number of viable
cells was determined using the CellTiter 96 aqueous One Solution
Cell Proliferation Assay (MTS; Promega, Madison, WI, USA)
according to the manufacturer’s instructions. Absorbance at
492 nm was determined on an automatic Titertek Multiskan Plus
MKII plate reader (LabX, Midland, Canada) and expressed as
a percentage of non-treated controls to calculate the percentage
proliferation status (Carmichael et al., 1987).
Statistical Analysis
All experiments were performed in triplicate on different days
unless otherwise stated in the text.
Trypan Blue Exclusion Test
Data were statistically analyzed using a Kruskal–Wallis One
way analysis of variance due to the data being non-normally
distributed.
Apoptotic Assay
Data were statistically treated using a Univariate General linear
model and Levene’s test.
MTS Assay
One-way between groups ANOVA with Tukey’s post hoc test was
used to compare cell viability as percentage of controls.
RESULTS
Trypan Blue Assay
The initial concentration of phage showed a non-significant
impact (p> 0.05) on the viability of 3T3 cells after 24 h exposure
(Figure 1) with 2 × 108 pfu/mL exhibiting the highest reduction
in viability (∼10%). Seeding density (5 × 103 or 2 × 105
cells/well) also had no significant effect on the viability of cells
following 24 h exposure to phage (p > 0.1 Tukey’s and Kruskal–
Wallis).
Hoechst and Propidium Iodide Staining
Statistically significant reductions in the number of viable cells
were observed following 72 h incubation with either 2 × 107
and 2 × 108 pfu/mL compared to untreated controls (Figure 2;
p < 0.001). Incubation time had no significant impact on cell
viability (p= 0.418).
LDH Release
Phage addition at varying concentrations resulted in small but
not statistically significant increases in cell death compared to
untreated samples (between 5 and 10% reduction; Figure 3) with
the exception of 2× 109 pfu/mL at 24 h (p< 0.001).
MTS Assay
Following 24 h exposure to different concentrations of phages
(2 × 109, 2 × 108, or 2 × 107 pfu/mL) the number of viable cells
appeared to increase at higher initial seeding densities (10000
and 15000 cells/well) compared to controls treated with λ buffer
only (Figure 4A). At 48 h incubation there was no significant
difference between phage samples and λ buffer (Figure 4B;
p> 0.5). After 72 h cells exposed to phages cell viability increased
significantly compared to the controls. Cells seeded at 10000
cells/well remained more viable (Figure 4C; p < 0.05) when
exposed to 2 × 109 and 2 × 108 pfu/mL phage, compared to λ
buffer and untreated (DMEM only) cells.
DISCUSSION
Bacterial cell products can have both direct and indirect
cytotoxic effects on cells in the stationary phase (Perfetto et al.,
2003), particularly through the action of bacterial endotoxins
which affect the expression of adhesion molecules, inflammatory
responses (Tang et al., 2011), cytokine release (Perfetto et al.,
2003; Tardif et al., 2004), or the release of bacterial toxins (Los
et al., 2013). However, little information exists in the current
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FIGURE 1 | 3T3 mouse fibroblast cell viability following 24 h exposure to Acinetobacter phage BS46 in DMEM by trypan blue exclusion assay. :
5 × 103 cells/well; : 2 × 105 cells/well. Data are the mean of 3 replicates ± SD.
FIGURE 2 | 3T3 mouse fibroblast cell viability following exposure to Acinetobacter phage BS46 by Hoechst propidium iodide staining. : 24, : 48
and : 72 h. Data shown are the mean of 3 replicates ± SD. ∗p < 0.05 compared to control, ∗∗p < 0.001 compared to controls and highest phage concentration
(2 × 109 pfu/mL) at 72 h.
literature on the effects of the direct addition of therapeutic
bacteriophages on immortalized cell lines such as 3T3 fibroblasts.
In the current investigation, a partially purified A. baumannii
phage preparation was not cytotoxic to 3T3 mouse fibroblast
cell line, although some assay dependent differences in viability
were observed. No statistically significant differences were
seen between 3T3 cells treated with phage and untreated
controls, corresponding with similar investigations performed
by Merabishvili et al. (2009) against human neonatal foreskin
keratinocytes when assessed by trypan blue exclusion. While
patient derived cells will offer the closest analog to whole
organism testing in vitro, the use of such cell types comes with
associated cost and ethical considerations as well as increased
variation between multiple donors. Although no substitute
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FIGURE 3 | LDH release of 3T3 mouse fibroblast cells following exposure to Acinetobacter phage BS46. ∗p < 0.001 compared to the control. : 24, :
48, and : 72 h. Data shown are the mean of 3 replicates ± SD.
FIGURE 4 | The effect of Acinetobacter phage BS46 on MTS formation of 3T3 cells. Percentage cell viability was calculated from the untreated cells which
represent 100% viability. Carrier control corresponds to cells treated with λ buffer. (A): 24 h, (B): 48 h, and (C): 72 h incubation.  5000 cells/well,  10000
cells/well and  15000 cells/well. ∗p < 0.05, compared to 2 × 107 pfu/mL; ∗∗p < 0.05 compared to λ buffer. Data are the mean of 3 replicates ± SD.
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for in vivo testing, the use of immortalized cell lines would
decrease the overall research cost of preclinical studies and
enable standardization between laboratories, allowing for better
comparative testing to be performed. In addition fibroblasts were
used in an attempt to understand the effect of phage on skin or
wounds, recognizing that A. baumannii is an important wound
pathogen.
Although no cytotoxic effect was observed with all the
assays tested, the assessment of cellular viability with the
MTS assay suggested that phages provided a positive effect
on cell viability. This observation supports that of Chung
et al. (2010) who reported that genetically engineered
M13 bacteriophage improved cell attachment under specific
experimental conditions. Although no direct cytotoxic effect
was observed, the addition of phages has been shown to
induce pro-inflammatory cytokines such as IL-10 and IFN-
γ (Da˛browska et al., 2014; Park et al., 2014). Majewska et al.
(2015) reported a weak antibody production in mice following
T4 phages ingestion. However, this is dependent on phage type
and the protein composition of individual phages (Da˛browska
et al., 2014) and would be of particular importance in non-
topical applications that would result in the increased exposure
of phages to the immune system (Hodyra-Stefaniak et al.,
2015). Here we have used a partially purified phage and it is
possible that bacterial debris were present in the preparation.
However, the phage preparation used here did not show any
cytotoxicity overall. The endotoxin level of any phage product
would need to be measured for regulatory purposes before
commercialization. A number of methods to reduce endotoxin
levels have been described: a single round of PEG precipitation
and centrifugation has been shown to remove up to 88%
of endotoxins from a bacteriophage preparation (Branston
et al., 2015). However, additional purification stages such as
ultracentrifugation in a CsCl gradient or chromatographic
methods will further reduce impurities (Boratyn´ski et al.,
2004).
The current investigation sought to assess the cytotoxicity
of a purified preparation of A. baumannii phage BS46 using
four separate methods. Some discrepancies in the results were
observed, notably at high phage concentrations, with the PI
and MTS assay showing some small but statistically significant
reduction in cell number and the LDH assay showing no
significant differences in cell viability. The LDH assay presented
the highest variability in results as indicated by the large
error bars. It measures the activity of the oxidoreductase
of LDH, a stable enzyme, released from damaged cells in
the culture medium. Variability in activity, which has been
reported in other applications (Bopp and Lettieri, 2008), may
be cause by differences in cell seeding. Such variability in
results was not noted with the other assays performed. Both
the Trypan blue exclusion assay and the Hoechst and PI
assays require microscope based analysis which may limit their
usefulness although high throughput protocol could potentially
be increased using flow cytometry. The MTS assay gives
indirect measurement of viability [requires metabolism of MTS
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium] to formazan and not a
measurement of cell damage. This indirect measurement based
on cell metabolism may explain why the MTS assay was the only
one that showed an increased in cell viability. For developing a
product for phage therapy, for which a high number of samples
need to be processed, the high throughput trypan blue assay may
be the most practical protocol to use. It is thus important to
consider the method used to assess the cytotoxic effects of phage
preparations and highlights the pressing need for standardized
phage testing protocols.
The purified phage suspension exhibited little toxicity and
this result is encouraging for the treatment of topical infections
with phages. For non-topical applications, the assessment of
cytotoxicity could be complemented with the determination of
immune-stimulatory capacity (Merabishvili et al., 2009; Szermer-
Olearnik and Boratyn´ski, 2015).
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